← Back to Manufacturing

Biological Product (except Diagnostic) Manufacturing

Industry Overview

Stock Screener

Select filters to narrow down the 162 companies below

162 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

AMGEN Inc.

AMGN

AMGEN Inc.

AMGN
Market Cap $182.21B
Dividends 2.9%
P/E Ratio 23.3
Revenue $8.62B +5.8%
Net Income $1.82B +5.1%
Profit Margin +21.1%
Employees 22K
View Stock

Gilead Sciences, Inc.

GILD

Gilead Sciences, Inc.

GILD
Market Cap $153.66B
Dividends 2.6%
P/E Ratio 16.7
Revenue $6.96B +4.4%
Net Income $2.02B +53.7%
Profit Margin +29.0%
View Stock

Argen X SE - ADR

ARGX

Argen X SE - ADR

ARGX
Market Cap $54.32B
Dividends 0.0%
P/E Ratio 49.7
Revenue $2.41B +84.6%
Net Income $875M +4.7%
Profit Margin +36.4%
View Stock

Seagen Inc

SGEN

Seagen Inc

SGEN
Market Cap $43.15B
Dividends 0.0%
P/E Ratio -69.2
Revenue $649M +27.1%
Net Income -$216M +13.1%
Profit Margin -33.3%
View Stock

Revolution Medicines Inc

RVMD

Revolution Medicines Inc

RVMD
Market Cap $34.65B
Dividends 0.0%
P/E Ratio -23.5
Revenue $0.00
Net Income -$454M +112.6%
Profit Margin
View Stock

Biogen Inc

BIIB

Biogen Inc

BIIB
Market Cap $29.02B
Dividends 0.0%
P/E Ratio 21.0
Revenue $2.48B +1.9%
Net Income $320M +32.8%
Profit Margin +12.9%
Employees 7.3K
View Stock

Moderna Inc

MRNA

Moderna Inc

MRNA
Market Cap $25.38B
Dividends 0.0%
P/E Ratio -7.9
Revenue $389M +263.6%
Net Income -$1.34B +38.3%
Profit Margin -345.2%
View Stock

BioNTech SE - ADR

BNTX

BioNTech SE - ADR

BNTX
Market Cap $22.98B
Dividends 0.0%
P/E Ratio -15.7
Revenue $120M -34.3%
Net Income -$541M +30.0%
Profit Margin -450.4%
View Stock

Neurocrine Biosciences, Inc.

NBIX

Neurocrine Biosciences, Inc.

NBIX
Market Cap $15.92B
Dividends 0.0%
P/E Ratio 23.8
Revenue $815M +42.2%
Net Income $198M +2405.1%
Profit Margin +24.3%
View Stock

Krystal Biotech Inc

KRYS

Krystal Biotech Inc

KRYS
Market Cap $10.26B
Dividends 0.0%
P/E Ratio 45.3
Revenue $116M +31.9%
Net Income $55.9M +56.5%
Profit Margin +48.1%
View Stock

Bio-Techne Corp

TECH

Bio-Techne Corp

TECH
Market Cap $9.07B
Dividends 0.6%
P/E Ratio 82.4
Revenue $311M -1.5%
Net Income $51.1M +126.0%
Profit Margin +16.4%
Employees 2.1K
View Stock

Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HALO
Market Cap $8.13B
Dividends 0.0%
P/E Ratio 23.5
Revenue $377M +42.2%
Net Income $150M +27.1%
Profit Margin +39.8%
View Stock

ImmunityBio Inc

IBRX

ImmunityBio Inc

IBRX
Market Cap $7.71B
Dividends 0.0%
P/E Ratio -8.8
Revenue $44.2M +167.6%
Net Income -$633M +388.1%
Profit Margin -1431.4%
Employees 171
View Stock

Qiagen NV

QGEN

Qiagen NV

QGEN
Market Cap $7.62B
Dividends 0.7%
P/E Ratio 19.0
Revenue $492M +1.8%
Net Income $68M -25.0%
Profit Margin +13.8%
View Stock

Repligen Corp.

RGEN

Repligen Corp.

RGEN
Market Cap $7.45B
Dividends 0.0%
P/E Ratio 144.8
Revenue $194M +14.8%
Net Income $8.33M +42.9%
Profit Margin +4.3%
View Stock

Vaxcyte Inc

PCVX

Vaxcyte Inc

PCVX
Market Cap $7.43B
Dividends 0.0%
P/E Ratio -7.6
Revenue $0.00
Net Income -$321M +127.8%
Profit Margin
Employees 14K
View Stock

Cidara Therapeutics Inc

CDTX

Cidara Therapeutics Inc

CDTX
Market Cap $5.61B
Dividends 0.0%
P/E Ratio -18.6
Revenue $0.00
Net Income -$83.2M +435.8%
Profit Margin
View Stock

CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

CRSP
Market Cap $5.22B
Dividends 0.0%
P/E Ratio -8.7
Revenue $1.46M
Net Income -$123M -9.6%
Profit Margin -8431.5%
View Stock

Opthea Limited - ADR

OPT

Opthea Limited - ADR

OPT
Market Cap $4.24B
Dividends 0.0%
P/E Ratio -6.3
Revenue $1.09k -98.3%
Net Income -$31.4M -74.7%
Profit Margin -2871059.9%
View Stock

Denali Therapeutics Inc

DNLI

Denali Therapeutics Inc

DNLI
Market Cap $3.7B
Dividends 0.0%
P/E Ratio -8.1
Revenue $0.00
Net Income -$128M -3.4%
Profit Margin
View Stock